Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Defina

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Cancer|October 24, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaAlessandro Gozzetti, Marzia Defina, Alberto Fabbri
Nature Reviews. Clinical Oncology|November 20, 2013
Treatment of smoldering multiple myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
Annals of Hematology|July 15, 2009
Cutaneous myeloma and bortezomibAlessandro Gozzetti, Marzia Defina, Monica Bocchia
Nature Reviews. Clinical Oncology|September 6, 2012
Lenalidomide maintenance in myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
International Journal of Hematology|January 9, 2014
Peptide vaccines for hematological malignancies: a missed promise?Monica Bocchia, Marzia Defina, Lara Aprile, et al.
Annals of Hematology|February 4, 2010
Hyperlipidemic myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia, et al.
European Journal of Haematology|November 16, 2011
Plasmacytoma of the skullAlessandro Gozzetti, Alfonso Cerase, Marzia Defina, et al.
Annals of Hematology|February 25, 2012
Extramedullary myeloma relapsesAlessandro Gozzetti, Giulia Papini, Marzia Defina, et al.
Nature Reviews. Clinical Oncology|September 9, 2010
Lenalidomide efficacy in bortezomib-resistant myelomaAlessandro Gozzetti, Rosaria Crupi, Marzia Defina, et al.
Leukemia Research|April 6, 2010
Hyperlipidemia in a myeloma patient after bortezomib treatmentAlessandro Gozzetti, Alberto Fabbri, Marzia Defina, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Cancer|October 24, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaAlessandro Gozzetti, Marzia Defina, Alberto Fabbri
Nature Reviews. Clinical Oncology|November 20, 2013
Treatment of smoldering multiple myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
Annals of Hematology|July 15, 2009
Cutaneous myeloma and bortezomibAlessandro Gozzetti, Marzia Defina, Monica Bocchia
Nature Reviews. Clinical Oncology|September 6, 2012
Lenalidomide maintenance in myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia
International Journal of Hematology|January 9, 2014
Peptide vaccines for hematological malignancies: a missed promise?Monica Bocchia, Marzia Defina, Lara Aprile, et al.
Annals of Hematology|February 4, 2010
Hyperlipidemic myelomaAlessandro Gozzetti, Marzia Defina, Monica Bocchia, et al.
European Journal of Haematology|November 16, 2011
Plasmacytoma of the skullAlessandro Gozzetti, Alfonso Cerase, Marzia Defina, et al.
Annals of Hematology|February 25, 2012
Extramedullary myeloma relapsesAlessandro Gozzetti, Giulia Papini, Marzia Defina, et al.
Nature Reviews. Clinical Oncology|September 9, 2010
Lenalidomide efficacy in bortezomib-resistant myelomaAlessandro Gozzetti, Rosaria Crupi, Marzia Defina, et al.
Leukemia Research|April 6, 2010
Hyperlipidemia in a myeloma patient after bortezomib treatmentAlessandro Gozzetti, Alberto Fabbri, Marzia Defina, et al.
Pageof 7